Half Year 2021 Business Update September 15, 2021 PARIS: IPH.PA NASDAQ: IPHA © 2021 Innate Pharma. All rights reserved. Disclaimer on Forward-Looking Information and Risk Factors This document has been prepared by Innate Pharma S.A. (the "Company") solely for the purposes of a presentation to investors concerning the Company. This document is not to be reproduced by any person, nor to be distributed. This document contains forward-looking statements. The use of certain words, including "believe," "potential ...

Innate Pharma S.A. (OTCPK:IPHYF) Q1 2021 Earnings Conference Call May 11, 2021 9:00 AM ET Company Participants Mondher Mahjoubi - Chairman of Executive Board & CEO Joyson Karakunnel - Executive VP & Chief Medical Officer Conference Call Participants Yigal Nochomovitz - Citigroup Daina Graybosch - SVB Leerink Swayampakula Ramakanth - H.C. Wainwright Liisa Bayko - Evercore Operator Good day, and thank you for standing by, and welcome to the Innate Pharma 2021 First Quarter Business Update Conference Call. [Op ...

Innate Pharma SA (OTCPK:IPHYF) Q4 2019 Results Conference Call March 10, 2020 9:00 AM ET Company Participants Danielle Spangler - Head of Investor Relations Mondher Mahjoubi - Chairman of the Executive Board and Chief Executive Officer Dr. Pierre Dodion - EVP and Chief Medical Officer Laure-Hélène Mercier - EVP and Chief Financial Officer Yannis Morel - EVP of Product Strategy Conference Call Participants Samantha Semenkow - Citigroup Swayampakula Ramakanth - H.C. Wainwright Daina Graybosch - SVB Leerink O ...